{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:00:34Z","timestamp":1782216034827,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T00:00:00Z","timestamp":1137110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T00:00:00Z","timestamp":1137110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1038\/sj.cdd.4401843","type":"journal-article","created":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T08:27:26Z","timestamp":1137140846000},"page":"773-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":284,"title":["Signals from within: the DNA-damage-induced NF-\u03baB response"],"prefix":"10.1038","volume":"13","author":[{"given":"S","family":"Janssens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tschopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,1,13]]},"reference":[{"key":"BF4401843_CR1","doi-asserted-by":"publisher","first-page":"RE1","DOI":"10.1126\/stke.1999.5.re1","volume":"1999","author":"DM Rothwarf","year":"1999","unstructured":"Rothwarf DM and Karin M (1999) The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE 1999: RE1","journal-title":"Sci. STKE"},{"key":"BF4401843_CR2","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS and Ghosh S (2004) Signaling to NF-kappaB. Genes Dev. 18: 2195\u20132224","journal-title":"Genes Dev."},{"key":"BF4401843_CR3","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 18: 6853\u20136866","journal-title":"Oncogene"},{"key":"BF4401843_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tibs.2003.12.003","volume":"29","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y and Gaynor RB (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 29: 72\u201379","journal-title":"Trends Biochem. Sci."},{"key":"BF4401843_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville MP, Bours V and Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30: 43\u201352","journal-title":"Trends Biochem. Sci."},{"key":"BF4401843_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1096\/fasebj.13.10.1137","volume":"13","author":"N Li","year":"1999","unstructured":"Li N and Karin M (1999) Is NF-kappaB the sensor of oxidative stress? FASEB J. 13: 1137\u20131143","journal-title":"FASEB J."},{"key":"BF4401843_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57: 727\u2013741","journal-title":"Biochem. Pharmacol."},{"key":"BF4401843_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1523-1747.ep12372194","volume":"102","author":"MM Simon","year":"1994","unstructured":"Simon MM, Aragane Y, Schwarz A, Luger TA and Schwarz T (1994) UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J. Invest. Dermatol. 102: 422\u2013427","journal-title":"J. Invest. Dermatol."},{"key":"BF4401843_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2307\/3578574","volume":"140","author":"N Mohan","year":"1994","unstructured":"Mohan N and Meltz ML (1994) Induction of nuclear factor kappa B after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway. Radiat. Res. 140: 97\u2013104","journal-title":"Radiat. Res."},{"key":"BF4401843_CR10","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1046\/j.1432-1327.2000.01421.x","volume":"267","author":"B Kaltschmidt","year":"2000","unstructured":"Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Droge W and Schmitz ML (2000) The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 267: 3828\u20133835","journal-title":"Eur. J. Biochem."},{"key":"BF4401843_CR11","doi-asserted-by":"publisher","first-page":"12952","DOI":"10.1074\/jbc.272.20.12952","volume":"272","author":"MP Boland","year":"1997","unstructured":"Boland MP, Foster SJ and O'Neill LA (1997) Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J. Biol. Chem. 272: 12952\u201312960","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR12","doi-asserted-by":"publisher","first-page":"48921","DOI":"10.1074\/jbc.M108674200","volume":"276","author":"X Bian","year":"2001","unstructured":"Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, Castle VP and Opipari Jr. AW (2001) NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem. 276: 48921\u201348929","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1042\/bj20020752","volume":"367","author":"S Wang","year":"2002","unstructured":"Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J and Kalyanaraman B (2002) Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem. J. 367: 729\u2013740","journal-title":"Biochem. J."},{"key":"BF4401843_CR14","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/emboj\/cdg332","volume":"22","author":"M Hayakawa","year":"2003","unstructured":"Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M and Kikugawa K (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 22: 3356\u20133366","journal-title":"EMBO J."},{"key":"BF4401843_CR15","doi-asserted-by":"publisher","first-page":"13012","DOI":"10.1073\/pnas.95.22.13012","volume":"95","author":"N Li","year":"1998","unstructured":"Li N and Karin M (1998) Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95: 13012\u201313017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF4401843_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.onc.1201638","volume":"16","author":"AC Hellin","year":"1998","unstructured":"Hellin AC, Calmant P, Gielen J, Bours V and Merville MP (1998) Nuclear factor-kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene 16: 1187\u20131195","journal-title":"Oncogene"},{"key":"BF4401843_CR17","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0891-5849(02)00743-8","volume":"32","author":"F Pajonk","year":"2002","unstructured":"Pajonk F, Riess K, Sommer A and McBride WH (2002) N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation. Free Radic. Biol. Med. 32: 536\u2013543","journal-title":"Free Radic. Biol. Med."},{"key":"BF4401843_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb07045.x","volume":"922","author":"S Miyamoto","year":"2000","unstructured":"Miyamoto S, Huang TT, Wuerzberger-Davis S, Bornmann WG, Pink JJ, Tagliarino C, Kinsella TJ and Boothman DA (2000) Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy. Ann. N.Y. Acad. Sci. 922: 274\u2013292","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF4401843_CR19","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1126\/science.8367725","volume":"261","author":"Y Devary","year":"1993","unstructured":"Devary Y, Rosette C, DiDonato JA and Karin M (1993) NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442\u20131445","journal-title":"Science"},{"key":"BF4401843_CR20","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1126\/science.274.5290.1194","volume":"274","author":"C Rosette","year":"1996","unstructured":"Rosette C and Karin M (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274: 1194\u20131197","journal-title":"Science"},{"key":"BF4401843_CR21","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1002\/j.1460-2075.1996.tb00916.x","volume":"15","author":"A Knebel","year":"1996","unstructured":"Knebel A, Rahmsdorf HJ, Ullrich A and Herrlich P (1996) Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15: 5314\u20135325","journal-title":"EMBO J."},{"key":"BF4401843_CR22","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1128\/jvi.63.11.4540-4544.1989","volume":"63","author":"B Stein","year":"1989","unstructured":"Stein B, Kramer M, Rahmsdorf HJ, Ponta H and Herrlich P (1989) UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells. J. Virol. 63: 4540\u20134544","journal-title":"J. Virol."},{"key":"BF4401843_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/1523-1747.ep12476573","volume":"100","author":"DB Yarosh","year":"1993","unstructured":"Yarosh DB, Alas L, Kibitel J, O'Connor A, Carrier F and Fornace Jr. AJ (1993) Cyclobutane pyrimidine dimers in UV-DNA induce release of soluble mediators that activate the human immunodeficiency virus promoter. J. Invest. Dermatol. 100: 790\u2013794","journal-title":"J. Invest. Dermatol."},{"key":"BF4401843_CR24","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1093\/emboj\/17.17.5170","volume":"17","author":"K Bender","year":"1998","unstructured":"Bender K, Gottlicher M, Whiteside S, Rahmsdorf HJ and Herrlich P (1998) Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. EMBO J. 17: 5170\u20135181","journal-title":"EMBO J."},{"key":"BF4401843_CR25","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1093\/nar\/24.21.4242","volume":"24","author":"B Piret","year":"1996","unstructured":"Piret B and Piette J (1996) Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. Nucleic Acids Res. 24: 4242\u20134248","journal-title":"Nucleic Acids Res."},{"key":"BF4401843_CR26","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1074\/jbc.275.13.9501","volume":"275","author":"TT Huang","year":"2000","unstructured":"Huang TT, Wuerzberger-Davis SM, Seufzer BJ, Shumway SD, Kurama T, Boothman DA and Miyamoto S (2000) NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J. Biol. Chem. 275: 9501\u20139509","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR27","doi-asserted-by":"publisher","first-page":"25231","DOI":"10.1074\/jbc.275.33.25231","volume":"275","author":"MP Boland","year":"2000","unstructured":"Boland MP, Fitzgerald KA and O'Neill LA (2000) Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells. J. Biol. Chem. 275: 25231\u201325238","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0968-0004(00)88993-8","volume":"20","author":"J Roca","year":"1995","unstructured":"Roca J (1995) The mechanisms of DNA topoisomerases. Trends Biochem. Sci. 20: 156\u2013160","journal-title":"Trends Biochem. Sci."},{"key":"BF4401843_CR29","first-page":"163","volume":"989","author":"P D'Arpa","year":"1989","unstructured":"D'Arpa P and Liu LF (1989) Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta 989: 163\u2013177","journal-title":"Biochim. Biophys. Acta"},{"key":"BF4401843_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/35044005","volume":"408","author":"BB Zhou","year":"2000","unstructured":"Zhou BB and Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408: 433\u2013439","journal-title":"Nature"},{"key":"BF4401843_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrc1011","volume":"3","author":"Y Shiloh","year":"2003","unstructured":"Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3: 155\u2013168","journal-title":"Nat. Rev. Cancer"},{"key":"BF4401843_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1101\/gad.13.8.916","volume":"13","author":"GC Smith","year":"1999","unstructured":"Smith GC and Jackson SP (1999) The DNA-dependent protein kinase. Genes Dev. 13: 916\u2013934","journal-title":"Genes Dev."},{"key":"BF4401843_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/21913","volume":"400","author":"GS Jimenez","year":"1999","unstructured":"Jimenez GS, Bryntesson F, Torres-Arzayus MI, Priestley A, Beeche M, Saito S, Sakaguchi K, Appella E, Jeggo PA, Taccioli GE, Wahl GM and Hubank M (1999) DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400: 81\u201383","journal-title":"Nature"},{"key":"BF4401843_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35043058","volume":"1","author":"MB Kastan","year":"2000","unstructured":"Kastan MB and Lim DS (2000) The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1: 179\u2013186","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BF4401843_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ and Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499\u2013506","journal-title":"Nature"},{"key":"BF4401843_CR36","doi-asserted-by":"publisher","first-page":"37538","DOI":"10.1074\/jbc.274.53.37538","volume":"274","author":"ST Kim","year":"1999","unstructured":"Kim ST, Lim DS, Canman CE and Kastan MB (1999) Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274: 37538\u201337543","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR37","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/sj.onc.1202088","volume":"17","author":"SJ Lee","year":"1998","unstructured":"Lee SJ, Dimtchev A, Lavin MF, Dritschilo A and Jung M (1998) A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 17: 1821\u20131826","journal-title":"Oncogene"},{"key":"BF4401843_CR38","doi-asserted-by":"publisher","first-page":"8898","DOI":"10.1074\/jbc.M009809200","volume":"276","author":"N Li","year":"2001","unstructured":"Li N, Banin S, Ouyang H, Li GC, Courtois G, Shiloh Y, Karin M and Rotman G (2001) ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276: 8898\u20138903","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR39","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/sj.onc.1202541","volume":"18","author":"B Piret","year":"1999","unstructured":"Piret B, Schoonbroodt S and Piette J (1999) The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 18: 2261\u20132271","journal-title":"Oncogene"},{"key":"BF4401843_CR40","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1038\/sj.onc.1206680","volume":"22","author":"T Criswell","year":"2003","unstructured":"Criswell T, Leskov K, Miyamoto S, Luo G and Boothman DA (2003) Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene 22: 5813\u20135827","journal-title":"Oncogene"},{"key":"BF4401843_CR41","first-page":"5456","volume":"59","author":"BP Ashburner","year":"1999","unstructured":"Ashburner BP, Shackelford RE, Baldwin Jr. AS and Paules RS (1999) Lack of involvement of ataxia telangiectasia mutated (ATM) in regulation of nuclear factor-kappaB (NF-kappaB) in human diploid fibroblasts. Cancer Res. 59: 5456\u20135460","journal-title":"Cancer Res."},{"key":"BF4401843_CR42","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/MCB.24.5.1823-1835.2004","volume":"24","author":"GR Panta","year":"2004","unstructured":"Panta GR, Kaur S, Cavin LG, Cortes ML, Mercurio F, Lothstein L, Sweatman TW, Israel M and Arsura M (2004) ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK\/extracellular signal-regulated kinase\/p90(rsk) signaling pathway in response to distinct forms of DNA damage. Mol. Cell. Biol. 24: 1823\u20131835","journal-title":"Mol. Cell. Biol."},{"key":"BF4401843_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1124\/mol.65.4.1038","volume":"65","author":"JD Bilyeu","year":"2004","unstructured":"Bilyeu JD, Panta GR, Cavin LG, Barrett CM, Turner EJ, Sweatman TW, Israel M, Lothstein L and Arsura M (2004) Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines. Mol. Pharmacol. 65: 1038\u20131047","journal-title":"Mol. Pharmacol."},{"key":"BF4401843_CR44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1998.8741","volume":"247","author":"S Basu","year":"1998","unstructured":"Basu S, Rosenzweig KR, Youmell M and Price BD (1998) The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem. Biophys. Res. Commun. 247: 79\u201383","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF4401843_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1097-2765(03)00223-5","volume":"12","author":"S Rocha","year":"2003","unstructured":"Rocha S, Campbell KJ and Perkins ND (2003) p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol. Cell 12: 15\u201325","journal-title":"Mol. Cell"},{"key":"BF4401843_CR46","first-page":"7785","volume":"61","author":"V Bottero","year":"2001","unstructured":"Bottero V, Busuttil V, Loubat A, Magne N, Fischel JL, Milano G and Peyron JF (2001) Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells. Cancer Res. 61: 7785\u20137791","journal-title":"Cancer Res."},{"key":"BF4401843_CR47","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1128\/MCB.22.16.5813-5825.2002","volume":"22","author":"TT Huang","year":"2002","unstructured":"Huang TT, Feinberg SL, Suryanarayanan S and Miyamoto S (2002) The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors. Mol. Cell. Biol. 22: 5813\u20135825","journal-title":"Mol. Cell. Biol."},{"key":"BF4401843_CR48","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1101\/gad.1062403","volume":"17","author":"GM Hur","year":"2003","unstructured":"Hur GM, Lewis J, Yang Q, Lin Y, Nakano H, Nedospasov S and Liu ZG (2003) The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev. 17: 873\u2013882","journal-title":"Genes Dev."},{"key":"BF4401843_CR49","first-page":"24","volume":"57","author":"M Jung","year":"1997","unstructured":"Jung M, Kondratyev A, Lee SA, Dimtchev A and Dritschilo A (1997) ATM gene product phosphorylates I kappa B-alpha. Cancer Res. 57: 24\u201327","journal-title":"Cancer Res."},{"key":"BF4401843_CR50","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/316914","volume":"67","author":"J Zonana","year":"2000","unstructured":"Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, Shapira SK, Farndon PA, Wara DW, Emmal SA and Ferguson BM (2000) A novel X-linked disorder of immune deficiency and hypohydrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 67: 1555\u20131562","journal-title":"Am. J. Hum. Genet."},{"key":"BF4401843_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/35013114","volume":"405","author":"A Smahi","year":"2000","unstructured":"Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israel A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA and Nelson DL (2000) Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405: 466\u2013472","journal-title":"Nature"},{"key":"BF4401843_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/85277","volume":"2","author":"A Jain","year":"2001","unstructured":"Jain A, Ma CA, Liu S, Brown M, Cohen J and Strober W (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat. Immunol. 2: 223\u2013228","journal-title":"Nat. Immunol."},{"key":"BF4401843_CR53","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/JCI0214858","volume":"109","author":"JS Orange","year":"2002","unstructured":"Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, Kretschmer R, Nurko S, Rasmussen WL, Kohler JR, Gellis SE, Ferguson BM, Strominger JL, Zonana J, Ramesh N, Ballas ZK and Geha RS (2002) Deficient natural killer cell cytotoxicity in patients with IKK-gamma\/NEMO mutations. J. Clin. Invest. 109: 1501\u20131509","journal-title":"J. Clin. Invest."},{"key":"BF4401843_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(03)00895-X","volume":"115","author":"TT Huang","year":"2003","unstructured":"Huang TT, Wuerzberger-Davis SM, Wu ZH and Miyamoto S (2003) Sequential modification of NEMO\/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565\u2013576","journal-title":"Cell"},{"key":"BF4401843_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ncb0204-89","volume":"6","author":"RT Hay","year":"2004","unstructured":"Hay RT (2004) Modifying NEMO. Nat. Cell Biol. 6: 89\u201391","journal-title":"Nat. Cell Biol."},{"key":"BF4401843_CR56","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.cub.2004.12.032","volume":"14","author":"DW Abbott","year":"2004","unstructured":"Abbott DW, Wilkins A, Asara JM and Cantley LC (2004) The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14: 2217\u20132227","journal-title":"Curr. Biol."},{"key":"BF4401843_CR57","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1097-2765(04)00236-9","volume":"14","author":"L Sun","year":"2004","unstructured":"Sun L, Deng L, Ea CK, Xia ZP and Chen ZJ (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14: 289\u2013301","journal-title":"Mol. Cell"},{"key":"BF4401843_CR58","doi-asserted-by":"publisher","first-page":"37297","DOI":"10.1074\/jbc.M303389200","volume":"278","author":"ED Tang","year":"2003","unstructured":"Tang ED, Wang CY, Xiong Y and Guan KL (2003) A role for NF-kappaB essential modifier\/IkappaB kinase-gamma (NEMO\/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J. Biol. Chem. 278: 37297\u201337305","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature02273","volume":"427","author":"H Zhou","year":"2004","unstructured":"Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W and Dixit VM (2004) Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature 427: 167\u2013171","journal-title":"Nature"},{"key":"BF4401843_CR60","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1095432","volume":"304","author":"A Tinel","year":"2004","unstructured":"Tinel A and Tschopp J (2004) The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304: 843\u2013846","journal-title":"Science"},{"key":"BF4401843_CR61","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","volume":"15","author":"A Kanayama","year":"2004","unstructured":"Kanayama A, Seth RB, Sun L, Ea CK, Hong M, Shaito A, Chiu YH, Deng L and Chen ZJ (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell 15: 535\u2013548","journal-title":"Mol. Cell"},{"key":"BF4401843_CR62","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S1097-2765(03)00358-7","volume":"12","author":"T Kato Jr.","year":"2003","unstructured":"Kato Jr. T, Delhase M, Hoffmann A and Karin M (2003) CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol. Cell 12: 829\u2013839","journal-title":"Mol. Cell"},{"key":"BF4401843_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0921-8777(90)90036-5","volume":"236","author":"T Teitz","year":"1990","unstructured":"Teitz T, Eli D, Penner M, Bakhanashvili M, Naiman T, Timme TL, Wood CM, Moses RE and Canaani D (1990) Expression of the cDNA for the beta subunit of human casein kinase II confers partial UV resistance on xeroderma pigmentosum cells. Mutat. Res. 236: 85\u201397","journal-title":"Mutat. Res."},{"key":"BF4401843_CR64","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/35009130","volume":"404","author":"KM Ryan","year":"2000","unstructured":"Ryan KM, Ernst MK, Rice NR and Vousden KH (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404: 892\u2013897","journal-title":"Nature"},{"key":"BF4401843_CR65","doi-asserted-by":"publisher","first-page":"26115","DOI":"10.1074\/jbc.M313509200","volume":"279","author":"J Bohuslav","year":"2004","unstructured":"Bohuslav J, Chen LF, Kwon H, Mu Y and Greene WC (2004) p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279: 26115\u201326125","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR66","first-page":"25","volume":"63","author":"I Lavon","year":"2003","unstructured":"Lavon I, Pikarsky E, Gutkovich E, Goldberg I, Bar J, Oren M and Ben-Neriah Y (2003) Nuclear factor-kappaB protects the liver against genotoxic stress and functions independently of p53. Cancer Res. 63: 25\u201330","journal-title":"Cancer Res."},{"key":"BF4401843_CR67","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/MCB.19.5.3485","volume":"19","author":"GA Webster","year":"1999","unstructured":"Webster GA and Perkins ND (1999) Transcriptional cross talk between NF-kappaB and p53. Mol. Cell. Biol. 19: 3485\u20133495","journal-title":"Mol. Cell. Biol."},{"key":"BF4401843_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.onc.1204168","volume":"20","author":"A Arlt","year":"2001","unstructured":"Arlt A, Vorndamm J, Breitenbroich M, Folsch UR, Kalthoff H, Schmidt WE and Schafer H (2001) Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 20: 859\u2013868","journal-title":"Oncogene"},{"key":"BF4401843_CR69","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.1074\/jbc.M111598200","volume":"277","author":"D Tang","year":"2002","unstructured":"Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW and Ingram AJ (2002) ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277: 12710\u201312717","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR70","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/emboj\/16.11.3133","volume":"16","author":"GJ Schouten","year":"1997","unstructured":"Schouten GJ, Vertegaal AC, Whiteside ST, Israel A, Toebes M, Dorsman JC, van der Eb AJ and Zantema A (1997) IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16: 3133\u20133144","journal-title":"EMBO J."},{"key":"BF4401843_CR71","first-page":"1425","volume":"54","author":"AC Koong","year":"1994","unstructured":"Koong AC, Chen EY and Giaccia AJ (1994) Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 54: 1425\u20131430","journal-title":"Cancer Res."},{"key":"BF4401843_CR72","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrm1368","volume":"5","author":"LF Chen","year":"2004","unstructured":"Chen LF and Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5: 392\u2013401","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BF4401843_CR73","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1097-2765(04)00131-5","volume":"13","author":"KJ Campbell","year":"2004","unstructured":"Campbell KJ, Rocha S and Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 13: 853\u2013865","journal-title":"Mol. Cell"},{"key":"BF4401843_CR74","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1042\/bst0290688","volume":"29","author":"KJ Campbell","year":"2001","unstructured":"Campbell KJ, Chapman NR and Perkins ND (2001) UV stimulation induces nuclear factor kappaB (NF-kappaB) DNA-binding activity but not transcriptional activation. Biochem. Soc. Trans. 29: 688\u2013691","journal-title":"Biochem. Soc. Trans."},{"key":"BF4401843_CR75","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1158\/0008-5472.CAN-04-3494","volume":"65","author":"WC Ho","year":"2005","unstructured":"Ho WC, Dickson KM and Barker PA (2005) Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. Cancer Res. 65: 4273\u20134281","journal-title":"Cancer Res."},{"key":"BF4401843_CR76","first-page":"4531","volume":"58","author":"R Ravi","year":"1998","unstructured":"Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ and Bedi A (1998) p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. 58: 4531\u20134536","journal-title":"Cancer Res."},{"key":"BF4401843_CR77","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S1097-2765(03)00227-2","volume":"11","author":"S Saccani","year":"2003","unstructured":"Saccani S, Pantano S and Natoli G (2003) Modulation of NF-kappaB activity by exchange of dimers. Mol. Cell 11: 1563\u20131574","journal-title":"Mol. Cell"},{"key":"BF4401843_CR78","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1097-2765(02)00477-X","volume":"9","author":"H Zhong","year":"2002","unstructured":"Zhong H, May MJ, Jimi E and Ghosh S (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP\/p300 or HDAC-1. Mol. Cell 9: 625\u2013636","journal-title":"Mol. Cell"},{"key":"BF4401843_CR79","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1062374","volume":"293","author":"L Chen","year":"2001","unstructured":"Chen L, Fischle W, Verdin E and Greene WC (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653\u20131657","journal-title":"Science"},{"key":"BF4401843_CR80","doi-asserted-by":"publisher","first-page":"32091","DOI":"10.1074\/jbc.274.45.32091","volume":"274","author":"W Vanden Berghe","year":"1999","unstructured":"Vanden Berghe W, De Bosscher K, Boone E, Plaisance S and Haegeman G (1999) The nuclear factor-kappaB engages CBP\/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274: 32091\u201332098","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR81","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1074\/jbc.M209572200","volume":"278","author":"R Kiernan","year":"2003","unstructured":"Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, Sardet C, Jin DY, Emiliani S and Benkirane M (2003) Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278: 2758\u20132766","journal-title":"J. Biol. Chem."},{"key":"BF4401843_CR82","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1172\/JCI11991","volume":"107","author":"AS Baldwin","year":"2001","unstructured":"Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107: 241\u2013246","journal-title":"J. Clin. Invest."},{"key":"BF4401843_CR83","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrc1588","volume":"5","author":"C Nakanishi","year":"2005","unstructured":"Nakanishi C and Toi M (2005) Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 5: 297\u2013309","journal-title":"Nat. Rev. Cancer"},{"key":"BF4401843_CR84","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1126\/science.274.5288.784","volume":"274","author":"CY Wang","year":"1996","unstructured":"Wang CY, Mayo MW and Baldwin Jr. AS (1996) TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784\u2013787","journal-title":"Science"},{"key":"BF4401843_CR85","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/7410","volume":"5","author":"CY Wang","year":"1999","unstructured":"Wang CY, Cusack Jr. JC, Liu R and Baldwin Jr. AS (1999) Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat. Med. 5: 412\u2013417","journal-title":"Nat. Med."},{"key":"BF4401843_CR86","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1128\/MCB.23.13.4713-4727.2003","volume":"23","author":"S Rocha","year":"2003","unstructured":"Rocha S, Martin AM, Meek DW and Perkins ND (2003) p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol. Cell. Biol. 23: 4713\u20134727","journal-title":"Mol. Cell. Biol."},{"key":"BF4401843_CR87","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.1523\/JNEUROSCI.23-24-08586.2003","volume":"23","author":"C Culmsee","year":"2003","unstructured":"Culmsee C, Siewe J, Junker V, Retiounskaia M, Schwarz S, Camandola S, El-Metainy S, Behnke H, Mattson MP and Krieglstein J (2003) Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J. Neurosci. 23: 8586\u20138595","journal-title":"J. Neurosci."},{"key":"BF4401843_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tcb.2003.12.004","volume":"14","author":"ND Perkins","year":"2004","unstructured":"Perkins ND (2004) NF-kappaB: tumor promoter or suppressor? Trends Cell. Biol. 14: 64\u201369","journal-title":"Trends Cell. Biol."},{"key":"BF4401843_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2005.09.036","volume":"123","author":"S Janssens","year":"2005","unstructured":"Janssens S, Tinel A, Lippens S and Tschopp J (2005) PIDD mediates NF-\u03baB activation in response to DNA damage. Cell 123: 1\u201314","journal-title":"Cell"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4401843.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4401843","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4401843.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:05:33Z","timestamp":1650341133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4401843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,13]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5,1]]}},"alternative-id":["BF4401843"],"URL":"https:\/\/doi.org\/10.1038\/sj.cdd.4401843","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,13]]},"assertion":[{"value":"13 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}